Treatment with biologic DMARDs may not adversely affect lung nodules in rheumatoid arthritis patients

• Hazan Karadeniz,
• Emetullah Cindil,
• Hakan Babaoğlu,
• Aslıhan Avanoğlu Güler,
• Reyhan Bilici Salman,
• Hasan Satış,
• Nuh Ataş,
• Berna Göker,
• Şeminur Haznedaroğlu,
• Mehmet Akif Öztürk,
• Abdurrahman Tufan

Affiliations

Hazan Karadeniz

Division of Rheumatology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey

Emetullah Cindil

Department of Radiology, Gazi University School of Medicine, Ankara, Turkey

Hakan Babaoğlu

Division of Rheumatology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey

Aslıhan Avanoğlu Güler

Division of Rheumatology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey

Reyhan Bilici Salman

Division of Rheumatology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey

Hasan Satış

Division of Rheumatology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey

Nuh Ataş

Division of Rheumatology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey

Berna Göker

Division of Rheumatology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey

Şeminur Haznedaroğlu

Division of Rheumatology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey

Mehmet Akif Öztürk

Division of Rheumatology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey

Abdurrahman Tufan

Division of Rheumatology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey